Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma
L. Sher (Rolling Hills Estates, CA, United States of America), G. Passalacqua (Genoa, Italy), C. Taillé (Paris, France), L. Cohn (New Haven, CT, United States of America), S. Quirce (Madrid, Spain), N. Daizadeh (Cambridge, MA, United States of America), N. Pandit-Abid (Bridgewater, NJ, United States of America), B. Ortiz (Tarrytown, NY, United States of America), A. Khan (Chilly-Mazarin, France), Y. Zhang (Tarrytown, NY, United States of America)
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Sher (Rolling Hills Estates, CA, United States of America), G. Passalacqua (Genoa, Italy), C. Taillé (Paris, France), L. Cohn (New Haven, CT, United States of America), S. Quirce (Madrid, Spain), N. Daizadeh (Cambridge, MA, United States of America), N. Pandit-Abid (Bridgewater, NJ, United States of America), B. Ortiz (Tarrytown, NY, United States of America), A. Khan (Chilly-Mazarin, France), Y. Zhang (Tarrytown, NY, United States of America). Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma. 3733
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: